GNI-104

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGNI-104
Drug Alias Nameed-004neutralizing monoclonal antibodies (Innogenetics)GNI-104
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEnvelope glycoprotein inhibitors
TargetsEnvelope glycoprotein
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGENimmune NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGENimmune NV
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A